Allay Therapeutics Completes Oversubscribed $60M Financing To Advance Ultra-Sustained Pain Platform
Amount Raised
$60 Million
Round Type
Funding Round
San JoseInformation TechnologyBiotechnologyDescription
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced the completion of its oversubscribed $60M Series C financing, led by Arboretum Ventures. Participating in the round were NEA, Temasek, Pavilion Capital, Brandon Capital Partners, Vertex Growth, Vertex Ventures HC and WTT Investment Ltd. The proceeds from the Series C will advance the Company’s lead candidate, ATX-101, into Phase 2b clinical trials, and support the further development of Allay’s platform for ultra-sustained analgesic products.
Quick answer
Allay Therapeutics raised $60 Million in a Funding Round round, dated September 15, 2021. Allay Therapeutics is based in San Jose, California, United States.
- How much did Allay Therapeutics raise?
- Allay Therapeutics raised $60 Million in a Funding Round round on September 15, 2021.
- What does Allay Therapeutics do?
- Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians.
- Where is Allay Therapeutics based and how big is it?
- Allay Therapeutics is based in San Jose, California, United States. Fundz records about 40 employees.
- Who are the decision-makers at Allay Therapeutics?
- Fundz holds 2 contacts at Allay Therapeutics, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Allay Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Jellatech raised $100K (Seed) on October 30, 2021.
- Elephas raised $1M on October 29, 2021.
- RedShift BioAnalytics raised $10M on October 29, 2021.
- OUROTECH, INC.- PEAR BIO raised $4.6M (Seed) on October 29, 2021.
- MED-X raised $1.2M on October 29, 2021.
- Gregor Diagnostics raised $5M on October 29, 2021.
Who to call at Allay Therapeutics, and when
A new round usually means Allay Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Allay Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Allay Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Allay Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Allay Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Allay Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.